Video | July 12, 2021

How A Patent Attorney Became A Biopharma CEO In The Middle Of COVID-19

Source: Life Science Leader

In this executive virtual roundtable (EVR) component, Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO of Vigil Neuroscience, a microglia-focused therapeutics company, shares how her biopharma career progressed from patent attorney to CEO, the important role played by networking, and the experience of coming in during the middle of COVID-19.

View the full presentation here.